United Kingdom Prenatal Genetic Testing Market Size, Growth & Revenue 2024-2034

The United Kingdom Prenatal Genetic Testing Market is a dynamic segment within the healthcare industry, focused on identifying genetic abnormalities in fetuses during pregnancy through advanced diagnostic and screening methodologies. This market encompasses a range of tests, including Non-Invasive Prenatal Testing (NIPT), Invasive Prenatal Testing (IPT), and carrier screening, all aimed at providing expectant parents and healthcare providers with critical information about fetal health and potential genetic conditions such as Down syndrome, cystic fibrosis, and sickle cell anemia. The scope of these services extends from early pregnancy screening to diagnostic confirmation, supporting informed decision-making throughout the prenatal period and contributing to personalized pregnancy management and improved long-term health outcomes for newborns.

Key market highlights indicate robust growth, with the UK Prenatal Genetic Testing Market projected to expand significantly from approximately USD 1.2 billion in 2024 to USD 3.5 billion by 2034, driven by a Compound Annual Growth Rate (CAGR) of 11.5%. Year-over-year growth is estimated at 10.2%, reflecting increasing adoption of advanced genetic technologies and heightened parental awareness. Non-invasive prenatal testing (NIPT) currently dominates the market, while carrier screening is identified as the fastest-growing product type.